A comparison of Bartonella henselae infection in immunocompetent and immunocompromised mice.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 05 10 2023
accepted: 02 01 2024
medline: 12 2 2024
pubmed: 12 2 2024
entrez: 12 2 2024
Statut: epublish

Résumé

Bartonellosis refers to disease caused by the Bartonella genus of bacteria. The breadth of disease manifestations associated with Bartonella is currently expanding and includes regional lymphadenopathy, rheumatic, ocular, and neurological disorders. The dearth of knowledge regarding diagnosis, treatment and pathogenesis of this disease can be partially attributed to the lack of a reliable small animal model for the disease. For this study, Bartonella henselae, the most common species associated with human disease, was injected into Swiss Webster (SW) mice. When the outcome indicated that productive infection did not occur, SCID/Beige (immune compromised) mice were inoculated. While SW mice may potentially harbor an acute infection, less than 10 days in length, the SCID/Beige model provided a sustained infection lasting up to 30-days. These data indicate that SCID/Beige mice can provide a model to study Bartonella infection, therapeutics, and vector dynamics in the future.

Identifiants

pubmed: 38346057
doi: 10.1371/journal.pone.0297280
pii: PONE-D-23-32460
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0297280

Informations de copyright

Copyright: © 2024 Bullard et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

Edward B. Breitschwerdt, DVM holds U.S. Patent No. 7115385; Media and Methods for cultivation of microorganisms, which was issued October 3, 2006. He is a co‐founder, shareholder and Chief Scientific Officer for Galaxy Diagnostics, a company that provides advanced diagnostic testing for the detection of Bartonella species infections. All other authors declare no potential conflicts of interest.

Auteurs

Rebekah L Bullard (RL)

Division of Immunology, Tulane University, Covington, Louisiana, United States of America.

Mercedes Cheslock (M)

Division of Immunology, Tulane University, Covington, Louisiana, United States of America.

Shiva Kumar Goud Gadila (SK)

Division of Immunology, Tulane University, Covington, Louisiana, United States of America.

Ricardo G Maggi (RG)

Intracellular Pathogens Research Laboratory, Department of Clinical Sciences, Comparative Medicine Institute, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, United States of America.

Edward B Breitschwerdt (EB)

Intracellular Pathogens Research Laboratory, Department of Clinical Sciences, Comparative Medicine Institute, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, United States of America.

Ahmad A Saied (AA)

Division of Comparative Pathology, Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.

Monica E Embers (ME)

Division of Immunology, Tulane University, Covington, Louisiana, United States of America.

Classifications MeSH